Trial Profile

Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial on the Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to SARS-CoV-2 Infection in Healthcare Personnel

Status: Withdrawn prior to enrolment

Phase of Trial: Phase III

Latest Information Update: 03 Nov 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

29 Oct 2020 Planned primary completion date changed from 1 Nov 2021 to 1 Dec 2021.
29 Oct 2020 Planned initiation date changed from 1 Jul 2020 to 1 Oct 2020.
29 Oct 2020 Status changed from not yet recruiting to withdrawn prior to enrolment as not authorized by Cofepris (Mexico Competent Regulatory Authority)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com